US President Trump tells TIME that he likes Anthropic's Amodei a lot

Presidential expressions of personal regard for individual company executives sit in a familiar category of Trump-era signalling: informal, relationship-driven, and historically an unreliable guide to policy, but not entirely without content.

Newsquawk StaffPublished On the live feed at — 6 more headlines followed before this page went public
Newsquawk headlinesUTC

Kone (KNEBV FH) reportedly prepares sale of TK Elevator's European business to tackle antitrust concerns

US President Trump sees a ramping up of bombing Iran after midterms as possible, reports Time Magazine

US President Trump tells TIME that he likes Anthropic's Amodei a lot

UnitedHealthCare (UNH) 2027 Medicare plans focus on affordability, simplicity and a more connected healthcare experience; more than 94% of Medicare-eligible individuals to have access to UnitedHealthcare plan in 2027

Lilly's (LLY) oral GLP-1, Foundayo (orforglipron), was associated with significant reductions in predicted long-term risk of type 2 diabetes and cardiovascular disease

Open the platform and use it. The whole workspace is free to try, with no signup and no card. When you want the headlines arriving live instead of on a delay, Newsquawk Pro is £24.99 for 7 days.

Free. No signup, no card.
Context

In past episodes of this kind, favourable mention of a firm's leadership has tended to precede, or at least coincide with, a softer regulatory or procurement posture toward that company, while public friction with executives has occasionally foreshadowed antitrust scrutiny, contract disputes, or exclusion from government business. Anthropic is a private company, so there is no listed equity to reprice directly; the transmission channel runs through the AI complex more broadly, through the competitive standing of listed peers and backers, and through the federal AI policy track where Anthropic has positioned itself as the regulation-friendly lab. The worthwatching follow-ons are whether the remark is followed by anything concrete: meetings, appointments, government contracts, or shifts in the administration's posture on AI safety frameworks and export controls, where the White House has previously reversed course on stated positions. As a standalone remark in an interview, the signal is directional and personal rather than policy-forming, and comparable utterances have frequently been walked back or contradicted within short order.

Related headlines

The whole workspace, free to try.

Try it free